Dossier
HER2-positive breast cancer
Coverage of HER2-positive breast cancer in the Nexus archive.
- HER2-Positive Breast Cancer and Brain Metastases
HER2-positive breast cancer patients have a 20% to 40% risk of developing brain metastases, which are associated with reduced survival rates and neurological complications such as headaches, seizures, and cognitive impairment.